Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Index
-
Market Cap
264.76M
Enterprise Value
263.59M
Income
6.75M
Sales
0.00M
Book/sh
8.05
Cash/sh
0.05
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
3
IPO
Dec 16, 2024
P/E
39.05
Forward P/E
-
PEG
-
P/S
-
P/B
1.33
P/C
224.37
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
0.73
Current Ratio
0.73
Debt/Eq
0.00
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
0.27
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
- -
EPS Y/Y TTM
39.00%
Sales Y/Y TTM
-
EPS Q/Q
-14.30%
Sales Q/Q
-
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
19.52%
Insider Trans
0.00%
Inst Own
76.61%
Inst Trans
-
ROA
3.33%
ROE
3.47%
ROIC
3.41%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
0.10%
SMA50
0.55%
SMA200
1.42%
Trades
Shs Outstand
19.78M
Shs Float
19.78M
52W High
10.88 -1.33%
52W Low
10.30 4.17%
Volatility
0.22% 0.21%
ATR (14)
0.04
RSI (14)
53.03
Beta
-0.01
Rel Volume
0.00
Avg Volume
41.30K
Volume
15
Perf Week
-0.09%
Perf Month
0.28%
Perf Quarter
0.85%
Perf Half Y
1.42%
Perf YTD
1.42%
Perf Year
2.68%
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
10.80
Price
10.73
Change %
-0.65%
Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.
CEO & DirectorMr. Zaid Pardesi
CFOMr. George A. Martinez
Chief Operation OfficerMr. Mathew M. Pendo